Abstract The three-dimensional (3D) printing and its extension four-dimensional (4D)
printing technique show great promise for advanced additive manufacturing of functional …

Structural heart disease (SHD) is a new field within cardiovascular medicine. Traditional
imaging modalities fall short in supporting the needs of SHD interventions, as they have …

Tricuspid regurgitation (TR) is an independent predictor of death. Lately, emerging
technologies for the treatment of TR have increased the interest of physicians. Due to the …

Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert
Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child. To …

Mastering the technical skills required to perform pediatric cardiac valve surgery is
challenging in part due to limited opportunity for practice. Transformation of 3D …

Primary or secondary tricuspid regurgitation (TR) represents an important health care
burden and challenge which has often been neglected or undertreated in the past. The …

Approximately 1.6 million patients in the United States are affected by tricuspid valve
regurgitation, which occurs when the tricuspid valve does not close properly to prevent …

The advent of novel transcatheter therapies for severe tricuspid regurgitation (TR) has
attracted much attention. Novel 3-dimensional imaging techniques have permitted analysis …

With the rate of cardiovascular diseases in the US increasing throughout the years, there is a
need for developing more advanced treatment plans that can be tailored to specific patients …

Background Recent advances in 3D printing technology, and biomaterials are
revolutionizing medicine. The beneficiaries of this technology are primarily patients, but also …